| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2095f6639ad7109856b5d23d2f200924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5468bac54abccfa19ddfa709873bcd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2015-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62df1834ac4ccf0a089dca1c5f3e736f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2230086bd280a46df194bd4545163eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86b33a06388388f773d9ed6e03ae1448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3cc2241117046ca9c14cc53b4c80cc3 |
| publicationDate |
2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2942540-A1 |
| titleOfInvention |
Antibody having infection-inhibiting activity against hepatitis c virus |
| abstract |
The present invention provides an anti-hepatitis-C-virus-E2-protein antibody or antigen-binding antibody fragment having infection-inhibiting activity against the hepatitis C virus (HCV). The present invention also provides an anti-hepatitis-C-virus-E2-protein antibody or antigen-binding antibody fragment having a specific variable region, having infection-inhibiting activity against the hepatitis C virus (HCV), and presenting the ability to suppress the appearance of escape variants. |
| priorityDate |
2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |